AllianceBernstein
TIL icon

AllianceBernstein’s Instil Bio TIL Stock Holding History

AllianceBernstein’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,905
Closed -$51.6K – 3242
2023
Q1 		$51.6K Hold
3,905
– – ﹤0.01% 3094
2022
Q4 		$49.2K Sell
3,905
-6,274
-62% -$310K ﹤0.01% 3174
2022
Q3 		$985K Buy
10,179
+430
+4% +$49.2K ﹤0.01% 2297
2022
Q2 		$901K Sell
9,749
-147,965
-94% -$21M ﹤0.01% 2406
2022
Q1 		$33.9M Buy
157,714
+4,824
+3% +$1.13M 0.01% 724
2021
Q4 		$52.3M Buy
152,890
+11,204
+8% +$4.32M 0.02% 610
2021
Q3 		$50.7M Sell
141,686
-816
-0.6% -$305K 0.02% 612
2021
Q2 		$55.1M Buy
142,502
+41,416
+41% +$15.4M 0.02% 590
2021
Q1 		$50.7M Buy
+101,086
New +$51.9M 0.02% 604

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's TIL Position: Q2 2023 in Review

AllianceBernstein sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 3,905 shares — an estimated $51.6K sold.

AllianceBernstein first reported a position in TIL in Q1 2021 and held it in 9 quarters. The position peaked at $55.1M in Q2 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • AllianceBernstein reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 3,905 Instil Bio shares in Q2 2023, an estimated $51.6K.
  • AllianceBernstein first reported a position in Instil Bio in Q1 2021 and held it in 9 quarters.
  • AllianceBernstein's Instil Bio position peaked at $55.1M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.